Skip to content
Share

|

eAlerts

|

Register

|

Login
  • Services
    • News Services
    • Conference Coverage & Reporting
    • Expert Interviews & Discussion
    • Featured Content Creation
    • Multimedia
  • Specialties
  • Showcase
  • Clients
  • News & Insights
  • About
  • Contact

Day: March 1, 2023

PRIME II ‘extremely reassuring’ on radiotherapy omission in older women with early breast cancer

The 10-year data from the PRIME II trial suggest that radiotherapy after breast-conserving surgery can be omitted for women aged 65 years or older with low-risk, hormone receptor-positive early breast cancer.

Building relationships through trusted content for healthcare professionals

GET STARTED
A global leader in medical content

© 2023 Springer Healthcare Limited.
Part of the Springer Nature Group.

Twitter Icon-social_rss
Social Share
Contact
eAlerts
Register
Login
Terms of Use
Privacy Policy
Cookie Policy